Skip to main navigation Skip to search Skip to main content

Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity

Research output: Contribution to journal › Article › peer-review

107   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology